Carbon Medical Technologies is committed to advancing cancer care through innovative medical solutions, including the groundbreaking BiomarC® fiducial markers. Designed to enhance precision in radiation therapy, markers enable accurate tumor targeting while minimizing damage to healthy tissue, improving patient outcomes for cancers such as prostate, lung, breast, liver, and pancreas. These products are crafted with pyrolytic carbon for exceptional durability and biocompatibility, and designed to offer radiographic visibility, reduced artifact, and minimized migration, making them an indispensable tool in modern oncology.

Carbon Medical Technologies is registered as a Small Business Enterprise (SBE).